Patents by Inventor James LaRocca

James LaRocca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11051659
    Abstract: A customizable toothbrush container, including a main body to receive at least a portion of a toothbrush therein, and a UV light disposed on at least a portion of an interior surface of the main body to sterilize the toothbrush in response to an illumination of the UV light.
    Type: Grant
    Filed: July 22, 2019
    Date of Patent: July 6, 2021
    Inventor: James LaRocca
  • Publication number: 20210022562
    Abstract: A customizable toothbrush container, including a main body to receive at least a portion of a toothbrush therein, and a UV light disposed on at least a portion of an interior surface of the main body to sterilize the toothbrush in response to an illumination of the UV light.
    Type: Application
    Filed: July 22, 2019
    Publication date: January 28, 2021
    Inventor: James LaRocca
  • Patent number: 6939677
    Abstract: A polypeptide has the antibody binding activity of the 46 Kdalton HMFG differentiation antigen and/or homology to at least one of the light chains of clotting factors V and VIII and is also provided as a fusion protein with a second antigenic polypeptide. An antibody has affinity for the polypeptide of the invention or a functional fragment thereof in vivo and in vitro methods for therapy vaccination and detecting the presence of the polypeptide, the antibody, the DNA and RNA of the invention are provided. DNA and RNA sequences encode the polypeptide of the invention or fragments thereof and immunoassay kits comprise the antibodies and/or polypeptides of the invention.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 6, 2005
    Assignee: Cancer Research Fund of Contra Costa
    Inventors: Roberto Luis Ceriani, Jerry Arthur Peterson, David James Larocca
  • Publication number: 20040076629
    Abstract: A polypeptide has the antibody binding activity of the 46K dalton HMFG differentiation antigen and/or homology to at least one of the light chains of clotting factors V and VIII and is also provided as a fusion protein with a second antigenic polypeptide. An antibody has affinity for the polypeptide of the invention or a functional fragment thereof in vivo and in vitro methods for therapy vaccination and detecting the presence of the polypeptide, the antibody, the DNA and RNA of the invention are provided. DNA and RNA sequences encode the polypeptide of the invention or fragments thereof and immunoassay kits comprise the antibodies and/or polypeptides of the invention.
    Type: Application
    Filed: January 2, 2002
    Publication date: April 22, 2004
    Applicant: Cancer Research Fund of Contra Costa
    Inventors: Roberto Luis Ceriani, Jerry Arthur Peterson, David James Larocca